Literature DB >> 21252928

Comparative effectiveness: the fourth hurdle in drug development and a role for clinical pharmacology.

P K Honig.   

Abstract

Mesh：

Year:  2011        PMID： 21252928     DOI： 10.1038/clpt.2010.302

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

Review 1.  The future of the pharmaceutical sciences and graduate education: recommendations from the AACP Graduate Education Special Interest Group.

Authors:  Susanna Wu-Pong; Jogarao Gobburu; Stephen O'Barr; Kumar Shah; Jason Huber; Daniel Weiner
Journal:  Am J Pharm Educ       Date:  2013-05-13       Impact factor: 2.047

2.  New drugs: evidence relating to their therapeutic value after introduction to the market.

Authors:  Mariam Ujeyl; Claudia Schlegel; Siegbert Walter; Ursula Gundert-Remy
Journal:  Dtsch Arztebl Int       Date:  2012-02-17       Impact factor: 5.594

3.  The value proposition of molecular medicine.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

4.  Analysing coverage decision-making: opening Pandora's box?

Authors:  Katharina Elisabeth Fischer; Reiner Leidl
Journal:  Eur J Health Econ       Date:  2014-02-06

5.  Clinical pharmacology at the core of translational science.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

6.  The diminished pipeline for medications to treat mental health and substance use disorders.

Authors:  Peggy L O'Brien; Cindy Parks Thomas; Dominic Hodgkin; Katharine R Levit; Tami L Mark
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.